| 000 | 01523 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250517170623.0 | ||
| 264 | 0 | _c20180507 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1665-2681 | ||
| 024 | 7 |
_a10.5604/01.3001.0010.2829 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaneja, Sunil | |
| 245 | 0 | 0 |
_aAcute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment. _h[electronic resource] |
| 260 |
_bAnnals of hepatology _c |
||
| 300 |
_a818-821 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xdiagnosis |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aEtodolac _xadverse effects |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatic Encephalopathy _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Failure, Acute _xchemically induced |
| 650 | 0 | 4 | _aLiver Function Tests |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aKumar, Pramod | |
| 700 | 1 | _aRathi, Sahaj | |
| 700 | 1 | _aDuseja, Ajay | |
| 700 | 1 | _aSingh, Virendra | |
| 700 | 1 | _aDhiman, Radha Krishan | |
| 700 | 1 | _aChawla, Yogesh Kumar | |
| 773 | 0 |
_tAnnals of hepatology _gvol. 16 _gno. 5 _gp. 818-821 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5604/01.3001.0010.2829 _zAvailable from publisher's website |
| 999 |
_c27467135 _d27467135 |
||